Olanzapine to prevent vomiting in kids on strong chemo
Treatments studied
Part of Cancer clinical trials.
This trial tests if adding olanzapine to standard anti-nausea medicines can better prevent vomiting in children and teens who still vomit despite current treatment. It aims to help those aged 5 to 18 receiving strong chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 5 and 18 years old
- You have a cancer diagnosis
- You weigh at least 22 pounds (10 kg)
- You are receiving strong chemotherapy that often causes vomiting
- You have had vomiting despite taking standard anti-nausea drugs
- You have a good overall health level (able to do daily activities)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new, easy-to-take film that melts on the tongue to prevent vomiting caused by radiation therapy in children with cancer. It may be a good option if your child is getting radiation to the belly or spine and has trouble swallowing pills.
This trial compares two anti-nausea drug regimens (one with olanzapine, one with dexamethasone) to prevent delayed nausea and vomiting after a stem cell transplant for multiple myeloma. It aims to find which is better at controlling these side effects.
This study tests if the drug olanzapine (commonly used for nausea) can help prevent vomiting in people receiving moderately strong chemotherapy for the first time. It may be a good fit if you're about to start treatment with oxaliplatin, irinotecan, or carboplatin and haven't had severe nausea treatments before.
This study tests whether olanzapine, a medication that can increase appetite, helps prevent severe appetite loss and muscle wasting in patients with ovarian or stomach cancer who are receiving chemotherapy before surgery. The goal is to help patients maintain nutrition and strength during treatment.
This trial tests whether a medication called olanzapine can help reduce nausea and loss of appetite in patients receiving chemotherapy before surgery for stomach cancer. The goal is to help you feel better and maintain nutrition during your cancer treatment.
This trial tests if the drug olanzapine can help improve appetite in people with head and neck cancer who are getting chemotherapy and radiation. It aims to prevent or reduce weight loss during treatment.
Hear when a new Pediatric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.